
Lifesaving bedside stroke test receives UK product safety mark
A revolutionary ward-based genetic test which can prevent stroke related death has received a UKCA product mark, paving the way for its introduction to the NHS.
Read moreA revolutionary ward-based genetic test which can prevent stroke related death has received a UKCA product mark, paving the way for its introduction to the NHS.
Read moreFor a nine-year old boy and his family, being part of Duchenne Muscular Dystrophy clinical research at NIHR Manchester CRF at Royal Manchester Children's Hospital has been ‘amazing,’ for many reasons.
Read moreManchester researchers have shown for the first time that a drop in the levels of an enzyme in the kidney is associated with high blood pressure.
Read more10 MFT clinicians are among 15 outstanding individuals announced by Manchester Academic Health Science Centre (MAHSC) as Honorary Clinical Chairs for 2023
Read moreA major UK study has discovered that the disturbed sleep patterns in patients hospitalised with COVID-19 was likely to be a driver of breathlessness.
Read moreThe NIHR has awarded more than £96 million to 93 NHS organisations as part of a capital investment – with £2.26 million awarded to MFT.
Read moreAn innovative genetic test that can help prevent newborn babies from going deaf if treated with a common antibiotic, is now being used in routine clinical practice in maternity settings at MFT.
Read moreA new platform has been announced, bringing together UK strengths in rare diseases research to improve diagnosis and treatment.
Read more